Fluorescence-based techniques for investigating estrogen receptor dynamics

키워드

참고문헌 (100)

1. Fuentes N, "Estrogen receptor signaling mechanisms", Adv Protein Chem Struct Biol, 116, pp.135~170 (2019)
2. Arao Y, "The physiological role of estrogen receptor functional domains", Essays Biochem, 65, pp.867~875 (2021)
3. Jia M, "Estrogen receptor alpha and beta in health and disease", Best Pract Res Clin Endocrinol Metab, 29, pp.557~568 (2015)
4. Chen P, "Role of estrogen receptors in health and disease", Front Endocrinol(Lausanne), 13, pp.839005~ (2022)
5. Filardo EJ, "Minireview : G proteincoupled estrogen receptor-1, GPER-1 : its mechanism of action and role in female reproductive cancer, renal and vascular physiology", Endocrinology, 153, pp.2953~2962 (2012)
6. Tamrazi A, "Estrogen receptor dimerization : ligand binding regulates dimer affinity and dimer dissociation rate", Mol Endocrinol, 16, pp.2706~2719 (2002)
7. Klinge CM, "Estrogen receptor interaction with estrogen response elements", Nucleic Acids Res, 29, pp.2905~2919 (2001)
8. DeLeon C, "G protein-coupled estrogen receptor, GPER1, offers a novel target for the treatment of digestive diseases", Front Endocrinol(Lausanne), 11, pp.578536~ (2020)
9. Björnström L, "Mechanisms of estrogen receptor signaling : convergence of genomic and nongenomic actions on target genes", Mol Endocrinol, 19, pp.833~842 (2005)
10. Bennesch MA, "Minireview : tipping the balance : ligand-independent activation of steroid receptors", Mol Endocrinol, 29, pp.349~363 (2015)
11. Shanle EK, "Endocrine disrupting chemicals targeting estrogen receptor signaling : identification and mechanisms of action", Chem Res Toxicol, 24, pp.6~19 (2011)
12. Yoon K, "Estrogenic endocrine-disrupting chemicals : molecular mechanisms of actions on putative human diseases", J Toxicol Environ Health B Crit Rev, 17, pp.127~174 (2014)
13. Campbell CG, "Biologically directed environmental monitoring, fate, and transport of estrogenic endocrine disrupting compounds in water : a review", Chemosphere, 65, pp.1265~1280 (2006)
14. Rotroff DM, "Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals", Environ Health Perspect, 121, pp.7~14 (2013)
15. Jacoby-Morris K, "Choosing fluorescent probes and labeling systems", Methods Mol Biol, 2304, pp.37~64 (2021)
16. Fili N, "Fluorescence and labelling : how to choose and what to do", Exp Suppl, 105, pp.1~24 (2014)
17. Mocanu MM, "Comparative analysis of fluorescence resonance energy transfer(FRET)and proximity ligation assay(PLA)", Proteomics, 11, pp.2063~2070 (2011)
18. Gautier A, "An engineered protein tag for multiprotein labeling in living cells", Chem Biol, 15, pp.128~136 (2008)
19. Schneider AFL, "Fluorescent labelling in living cells", Curr Opin Biotechnol, 48, pp.61~68 (2017)
20. Hoelzel CA, "Visualizing and manipulating biological processes by using HaloTag and SNAP-tag technologies", ChemBioChem, 21, pp.1935~1946 (2020)
21. Specht EA, "A critical and comparative review of fluorescent tools for live-cell imaging", Annu Rev Physiol, 79, pp.93~117 (2017)
22. Wu Y, "Developments in FRET-and BRET-based biosensors", Micromachines, 13, pp.1789~ (2022)
23. Htun H, "Direct visualization of the human estrogen receptor  reveals a role for ligand in the nuclear distribution of the receptor", Mol Biol Cell, 10, pp.471~486 (1999)
24. Hu Z, "A high-affinity subtype-selective fluorescent probe for estrogen receptor  imaging in living cells", Chem Commun, 54, pp.3887~3890 (2018)
25. Xie B, "Estrogen receptor -targeted hypoxia-responsive near-infrared fluorescence probes for prostate cancer study", Eur J Med Chem, 238, pp.114506~ (2022)
26. Yang S-H, "Mitochondrial localization of estrogen receptor ", Proc Natl Acad Sci U S A, 101, pp.4130~4135 (2004)
27. Casa AJ, "The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor", Mol Cell Endocrinol, 415, pp.76~86 (2015)
28. Matsuda K, "Colocalization and ligand-dependent discrete distribution of the estrogen receptor(ER) and ER", Mol Endocrinol, 16, pp.2215~2230 (2002)
29. Kocanova S, "Ligands specify estrogen receptor alpha nuclear localization and degradation", BMC Cell Biol, 11, pp.1~13 (2010)
30. Hua H, "Mechanisms for estrogen receptor expression in human cancer", Exp Hematol Oncol, 7, pp.24~ (2018)
31. Tang C, "A novel estrogen receptor -targeted near-infrared fluorescent probe for in vivo detection of breast tumor", Mol Pharm, 15, pp.4702~4709 (2018)
32. He P, "Development of highly efficient estrogen receptor -targeted near-infrared fluorescence probes triggered by endogenous hydrogen peroxide for diagnostic imaging of prostate cancer", Molecules, 28, pp.2309~ (2023)
33. Zhang G, "Advancing breast cancer diagnosis with a near-infrared fluorescence imaging smart sensor for estrogen", progesterone receptor detection, 2023, pp.13, 21086~
34. Métivier R, "A dynamic structural model for estrogen receptor- activation by ligands, emphasizing the role of interactions between distant A and E domains", Mol Cell, 10, pp.1019~1032 (2002)
35. Rajbhandari P, "Regulation of estrogen receptor  N-terminus conformation and function by peptidyl prolyl isomerase Pin1", Mol Cell Biol, 32, pp.445~457 (2012)
36. Cagnet S, "Oestrogen receptor  AF-1 and AF-2 domains have cell populationspecific functions in the mammary epithelium", Nat Commun, 9, pp.4723~ (2018)
37. Björnström L, "Estrogen receptordependent activation of AP-1 via non-genomic signalling", Nucl Recept, 2, pp.3~ (2004)
38. Azuma K, "Analysis of estrogen receptor signaling complex at the plasma membrane", FEBS Lett, 577, pp.339~344 (2004)
39. Berno V, "Activation of estrogen receptor- by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription", PLoS One, 3, pp.e2286~ (2008)
40. Zwart W, "The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen", J Cell Sci, 123, pp.1253~1261 (2010)
41. Vallet A, "The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens", J Biol Chem, 299, pp.102757~ (2023)
42. Weinberg AL, "The DNA binding domain of estrogen receptor  is required for high-affinity nuclear interaction induced by estradiol", Biochemistry, 46, pp.8933~8942 (2007)
43. Burns KA, "Selective mutations in estrogen receptor  Ddomain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms", J Biol Chem, 286, pp.12640~12649 (2011)
44. Murata M, "Novel biosensor for the rapid measurement of estrogen based on a ligand-receptor interaction", Anal Sci, 17, pp.387~390 (2001)
45. La Spina R, "Label-free biosensor detection of endocrine disrupting compounds using engineered estrogen receptors", Biosensors, 8, pp.1~ (2017)
46. Kim SH, "Estrogen receptor microarrays : subtype-selective ligand binding", J Am Chem Soc, 126, pp.4754~4755 (2004)
47. Yang L, "Estrogen receptor sensing in living cells by a high affinity turn-on fluorescent probe", Sensors Actuators B: Chem, 272, pp.589~597 (2018)
48. Díaz M, "Fluorescent tamoxifen derivatives as biophotonic probes for the study of human breast cancer and estrogenreceptor directed photosensitizers", Opt Mater, 138, pp.113736~ (2023)
49. Ohno K, "Estrogen receptor binding assay method for endocrine disruptors using fluorescence polarization", Anal Chem, 74, pp.4391~4396 (2002)
50. Tirri ME, "Two-photon excitation in fluorescence polarization receptor-ligand binding assay", SLAS Discov, 10, pp.314~319 (2005)
51. Beekman JM, "Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain", Mol Endocrinol, 7, pp.1266~1274 (1993)
52. Gee AC, "Probing conformational changes in the estrogen receptor : evidence for a partially unfolded intermediate facilitating ligand binding and release", Mol Endocrinol, 15, pp.421~428 (2001)
53. Ho BK, "Probing the flexibility of large conformational changes in protein structures through local perturbations", PLoS Comp Biol, 5, pp.e1000343~ (2009)
54. De S, "Novel biosensors for the detection of estrogen receptor ligands", J Steroid Biochem Mol Biol, 96, pp.235~244 (2005)
55. McLachlan MJ, "A new fluorescence complementation biosensor for detection of estrogenic compounds", Biotechnol Bioeng, 108, pp.2794~2803 (2011)
56. Awais M, "A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells", Anal Chem, 76, pp.2181~2186 (2004)
57. Gunther JR, "A set of timeresolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptorcoactivator binding", J Biomol Screen, 14, pp.181~193 (2009)
58. Moore TW, "Estrogen receptor alpha", co-activator interaction assay : TR-FRET, 2015, pp.1278, 545~553
59. Kim SB, "Single-chain multicolor-reporter templates for subcellular localization of molecular events in mammalian cells", RSC Chem Biol, 4, pp.1043~1049 (2023)
60. Kumar R, "The dynamic structure of the estrogen receptor", J Amino Acids, 2011, pp.812540~ (2011)
61. Song D, "ER and ERhomodimers in the same cellular context regulate distinct transcriptomes and functions", Front Endocrinol(Lausanne), 13, pp.930227~ (2022)
62. Monroe DG, "Estrogen receptor and  heterodimers exert unique effects on estrogen-and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells", Mol Endocrinol, 19, pp.1555~1568 (2005)
63. Li X, "Single-chain estrogen receptors(ERs)reveal that the ER",  heterodimer emulates functions of the ERdimer in genomic estrogen signaling pathways, 2004, pp.24, 7681~7694
64. Iwabuchi E, "Visualization of the protein–protein interactions of hormone receptors in hormone-dependent cancer research", Endocr Oncol, 2, pp.R132~R142 (2022)
65. Majumdar S, "Differential actions of estrogen receptor  and  via nongenomic signaling in human prostate stem and progenitor cells", Endocrinology, 160, pp.2692~2708 (2019)
66. Muddana SS, "Fluorescent cellular sensors of steroid receptor ligands", Chembiochem, 4, pp.848~855 (2003)
67. Bai Y, "Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells", Mol Endocrinol, 17, pp.589~599 (2003)
68. Kim HM, "Development of a human estrogen receptor dimerization assay for the estrogenic endocrine-disrupting chemicals using bioluminescence resonance energy transfer", Int J Environ Res Public Health, 18, pp.8875~ (2021)
69. Powell E, "Intermolecular interactions identify ligand-selective activity of estrogen receptor ", dimers, 2008, pp.105, 19012~19017
70. Choi G, "Novel estrogen receptor dimerization BRET-based biosensors for screening estrogenic endocrine-disrupting chemicals", Biomater Res, 28, pp.0010~ (2024)
71. Iwabuchi E, "In situ evaluation of estrogen receptor dimers in breast carcinoma cells : visualization of protein-protein interactions", Acta Histochem Cytochem, 50, pp.85~93 (2017)
72. Bafna D, "Computer-aided ligand discovery for estrogen receptor alpha", Int J Mol Sci, 21, pp.4193~ (2020)
73. Duijndam B, "Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicals", Toxicol In Vitro, 81, pp.105348~ (2022)
74. Miller S, "A rapid and sensitive reporter gene that uses green fluorescent protein expression to detect chemicals with estrogenic activity", Toxicol Sci, 55, pp.69~77 (2000)
75. Beck V, "GFP-reporter for a high throughput assay to monitor estrogenic compounds", J Biochem Biophys Methods, 64, pp.19~37 (2005)
76. Fujiki N, "Estrogen response element-GFP(ERE-GFP)introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms", J Steroid Biochem Mol Biol, 139, pp.61~72 (2014)
77. Kim K, "Analysis of estrogen receptor -Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer", Mol Endocrinol, 19, pp.843~854 (2005)
78. Likhite VS, "Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity", Mol Endocrinol, 20, pp.3120~3132 (2006)
79. Ciana P, "Engineering of a mouse for the in vivo profiling of estrogen receptor activity", Mol Endocrinol, 15, pp.1104~1113 (2001)
80. Ciana P, "In vivo imaging of transcriptionally active estrogen receptors", Nat Med, 9, pp.82~86 (2003)
81. Maggi A, "In vivo dynamics of estrogen receptor activity : the ERE-Luc model", J Steroid Biochem Mol Biol, 139, pp.262~269 (2014)
82. Prossnitz ER, "The G proteincoupled oestrogen receptor GPER in health and disease : an update", Nat Rev Endocrinol, 19, pp.407~424 (2023)
83. Cortes E, "Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor", Oncogene, 38, pp.2910~2922 (2019)
84. Li R, "Gprotein coupled estrogen receptor activation protects the viability of hyperoxia-treated primary murine retinal microglia by reducing ER stress", Aging(Albany NY), 12, pp.17367~ (2020)
85. Chevalier N, "GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation", PloS One, 7, pp.e34672~ (2012)
86. Bai N, "G-protein-coupled estrogen receptor activation upregulates interleukin-1 receptor antagonist in the hippocampus after global cerebral ischemia : implications for neuronal self-defense", J Neuroinflammation, 17, pp.1~18 (2020)
87. Cheng SB, "Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway", J Biol Chem, 286, pp.22441~22455 (2011)
88. Lachowski D, "G protein-coupled estrogen receptor regulates actin cytoskeleton dynamics to impair cell polarization", Front Cell Dev Biol, 8, pp.592628~ (2020)
89. Rice A, "GPER activation inhibits cancer cell mechanotransduction and basement membrane invasion via RhoA", Cancers, 12, pp.289~ (2020)
90. Yu T, "Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP", PKA, glycolytic axis to confer tumor cells with multidrug resistance, pp.Oncogene, 2017[DOI]
91. Ke R, "Formation of Kiss1R", GPER heterocomplexes negatively regulates Kiss1R-mediated signalling through limiting receptor cell surface expression, 2021, pp.433, 166843~
92. Hewitt SC, "Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus", Endocrinology, 147, pp.2203~2214 (2006)
93. Strillacci A, "ER-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance", NPJ Breast Cancer, 8, pp.96~ (2022)
94. Moriyama T, "Transportin-2 plays a critical role in nucleocytoplasmic shuttling of oestrogen receptor-", Sci Rep, 10, pp.18640~ (2020)
95. Rochefort H, "Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors", J Steroid Biochem, 12, pp.135~142 (1980)
96. Defranco DB, "Nucleocytoplasmic shuttling of steroid receptors", Vitam Horm, 51, pp.315~338 (1995)
97. Mazaira GI, "Nucleocytoplasmic shuttling of the glucocorticoid receptor is influenced by tetratricopeptide repeat-containing proteins", J Cell Sci, 133, pp.238873~ (2020)
98. Dull AB, "Identification of compounds by high-content screening that induce cytoplasmic to nuclear localization of a fluorescent estrogen receptor chimera and exhibit agonist or antagonist activity In Vitro", SLAS Discov, 19, pp.242~252 (2014)
99. De Marco P, "Insulinlike growth factor-I regulates GPER expression and function in cancer cells", Oncogene, 32, pp.678~688 (2013)
100. Maziarz M, "Revealing the activity of trimeric G-proteins in live cells with a versatile biosensor design", Cell, 182, pp.770~785 (2020)

관련 논문AI추천